Editorial

https://doi.org/10.5772/60126

Year of Expanding into Circulating Biomarkers

Shidong Jia ; Genentech Inc., South San Francisco, USA
Winston Patrick Kuo ; IES Diagnostics, Inc., Cambridge, USA

Abstract

This editorial article summarizes the achievements and current challenges for the Journal of Circulating Biomarkers (JCB) regarding a more strategic approach to branding and attracting a high quality variety of articles. More emphasis is placed on fostering engagement with academic and industry sources operating at the cutting-edge of translational technologies applied to the field of circulating biomarkers (interface between extracellular vesicles including exosomes and microvesicles, circulating tumour cells, cell-free circulating DNA and circulating protein markers) and with those in the investment arena seeking and providing private funding for this area of research.

Keywords

Extracellular vesicles; exosomes; microvesicles; circulating tumour cells; cell-free circulating DNA; editorial

Hrčak ID:

161407

URI

https://hrcak.srce.hr/161407

Publication date:

1.1.2015.

Visits: 1.442 *